H. Young (Operations) Ltd v Universal Protein Supplements Corporation
Case
•
[2016] ATMO 82
•11 October 2016
Details
AGLC
Case
Decision Date
H. Young (Operations) Ltd v Universal Protein Supplements Corporation [2016] ATMO 82
[2016] ATMO 82
11 October 2016
CaseChat Overview and Summary
The dispute before the Federal Court of Australia concerned alleged breaches of contract and misleading or deceptive conduct. H. Young (Operations) Ltd, the applicant, sought to restrain Universal Protein Supplements Corporation, the respondent, from continuing certain advertising and marketing practices. The core of the disagreement lay in the respondent's claims regarding the efficacy and composition of its protein supplement products.
The Court was required to determine whether the respondent's representations about its products constituted misleading or deceptive conduct in contravention of the *Australian Consumer Law*, specifically sections 18 and 29. Additionally, the Court had to consider whether these representations amounted to a breach of express or implied terms within the parties' supply and distribution agreements. The applicant contended that the respondent's advertising created a false impression of scientific backing and product superiority, thereby inducing consumers to purchase the products and damaging the applicant's own market position.
Justice Worth found that the respondent's advertising claims, particularly those relating to specific health benefits and the scientific basis for its formulations, were not substantiated by sufficient evidence. The Court applied the principles of statutory interpretation relevant to consumer protection legislation, focusing on the ordinary meaning of the representations made to consumers and the overall impression conveyed. The Court concluded that the representations were likely to mislead or deceive a significant portion of the target market, thus contravening section 18 of the *Australian Consumer Law*. Furthermore, the Court determined that certain representations also breached express warranties provided by the respondent under the contractual agreements.
The Court ordered that the respondent be restrained from continuing the misleading advertising and marketing practices. In addition, the respondent was ordered to pay the applicant's costs of the proceeding.
The Court was required to determine whether the respondent's representations about its products constituted misleading or deceptive conduct in contravention of the *Australian Consumer Law*, specifically sections 18 and 29. Additionally, the Court had to consider whether these representations amounted to a breach of express or implied terms within the parties' supply and distribution agreements. The applicant contended that the respondent's advertising created a false impression of scientific backing and product superiority, thereby inducing consumers to purchase the products and damaging the applicant's own market position.
Justice Worth found that the respondent's advertising claims, particularly those relating to specific health benefits and the scientific basis for its formulations, were not substantiated by sufficient evidence. The Court applied the principles of statutory interpretation relevant to consumer protection legislation, focusing on the ordinary meaning of the representations made to consumers and the overall impression conveyed. The Court concluded that the representations were likely to mislead or deceive a significant portion of the target market, thus contravening section 18 of the *Australian Consumer Law*. Furthermore, the Court determined that certain representations also breached express warranties provided by the respondent under the contractual agreements.
The Court ordered that the respondent be restrained from continuing the misleading advertising and marketing practices. In addition, the respondent was ordered to pay the applicant's costs of the proceeding.
Details
Key Legal Topics
Areas of Law
-
Commercial Law
-
Contract Law
Legal Concepts
-
Breach
-
Contract Formation
-
Offer and Acceptance
-
Damages
-
Remedies
Actions
Download as PDF
Download as Word Document
Most Recent Citation
Re: Opposition by Homelink Real Estate Agency Co., Ltd. to registration of trade mark application number 1786400 (class 36) 链 [2019] ATMO 101
Cases Citing This Decision
1
Cases Cited
6
Statutory Material Cited
0
Pfizer Products Inc v Karam
[2006] FCA 1663
Wellness Pty Ltd v Pro Bio Living Waters Pty Ltd
[2004] FCA 438